Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Incorporating liquid biopsies into clinical trials
Dr Daniel Hayes - University of Michigan Comprehensive Cancer Center, Ann Arbor,...
Incorporating liquid biopsies into clinical trials ( Dr Daniel Hayes - University of Michigan Comprehensive Cancer Center, Ann Arbor,  USA )
4 Jul 2017
DNA damage response inhibition
Dr Giorgio Massimini - Vice President, Head of Early Clinical Oncology, Merck, D...
DNA damage response inhibition ( Dr Giorgio Massimini - Vice President, Head of Early Clinical Oncology, Merck, Darmstadt, Germany )
4 Jul 2017
Big data, scientific wellness and transforming healthcare
Prof Leroy Hood - Systems Biology, Seattle, USA
Big data, scientific wellness and transforming healthcare ( Prof Leroy Hood - Systems Biology, Seattle, USA )
4 Jul 2017
Bayesian adaptive trial designs for precision medicine
Dr Jack Lee - MD Anderson Cancer Center, Houston, USA
Bayesian adaptive trial designs for precision medicine ( Dr Jack Lee - MD Anderson Cancer Center, Houston, USA )
4 Jul 2017
Redesigning clinical trials in the era of precision medicine
Dr Razelle Kurzrock - San Diego Moores Cancer Center, San Diego, USA
Redesigning clinical trials in the era of precision medicine ( Dr Razelle Kurzrock - San Diego Moores Cancer Center, San Diego, USA )
4 Jul 2017
Genomic-driven clinical studies in breast cancer
Prof José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA
Genomic-driven clinical studies in breast cancer ( Prof José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jul 2017
Genomic predictors of treatment response in prostate cancer
Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada
Genomic predictors of treatment response in prostate cancer ( Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada )
4 Jul 2017
Synthetic lethality as a basis to select drug combinations
Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland
Synthetic lethality as a basis to select drug combinations ( Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland )
4 Jul 2017
Genomic analysis of childhood tumours; biological and therapeutic implications
Dr Peter Lichter - German Cancer Research Center (DKFZ), Heidelberg, Germany
Genomic analysis of childhood tumours; biological and therapeutic implications ( Dr Peter Lichter - German Cancer Research Center (DKFZ), Heidelberg, Germany )
4 Jul 2017
Patient-specific peptide vaccines
Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany
Patient-specific peptide vaccines ( Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany )
4 Jul 2017
Proteogenomics in cancer research
Dr Henry Rodriguez - National Cancer Institute (NIH), Bethesda, USA
Proteogenomics in cancer research ( Dr Henry Rodriguez - National Cancer Institute (NIH), Bethesda, USA )
4 Jul 2017
Novel models to personalise cancer therapeutics
Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden
Novel models to personalise cancer therapeutics ( Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden )
4 Jul 2017